FNIP2 Recombinant antibody

FNIP2 Recombinant Antibody for WB, ELISA
Cat No. 84371-2-RR
Clone No.241638F2

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

KIAA1450, FNIPL, FNIP1 like protein, 241638F2

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inA549 cells, HeLa cells, MDA-MB-231 cells, MDA-MB-453 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

84371-2-RR targets FNIP2 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen FNIP2 fusion protein Ag35014 Predict reactive species
Full Name folliculin interacting protein 2
Observed Molecular Weight125 kda
GenBank Accession NumberBC166693
Gene Symbol FNIP2
Gene ID (NCBI) 57600
RRIDAB_3671906
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ9P278
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Folliculin (FLCN)-interacting proteins 1 and 2 (FNIP1, FNIP2) are homologous binding partners of FLCN, a tumor suppressor for kidney cancer. FNIP2 was found to bind to the C terminus of FLCN and to AMPK, like FNIP1. FNIP2 competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PMID: 18403135).

Protocols

Product Specific Protocols
WB protocol for FNIP2 antibody 84371-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...